08/21/2024 | Press release | Distributed by Public on 08/21/2024 14:40
Item 1.01 |
Entry into a Material Definitive Agreement |
As previously reported, Heart Test Laboratories, Inc. (the "Company") has an outstanding Loan and Security Agreement in the principal amount of $500,000 (the "Loan and Security Agreement") with Front Range Ventures LLC ("FRV") evidenced by a secured, non-convertible promissory note. The loan accrues interest at a rate of 12% per annum, compounded annually, and had an original maturity date of September 30, 2021, which has been subsequently amended to, among other things, extend the maturity date on several occasions, the most recent extension being September 30, 2024.
On August 19, 2024 the Company and FRV entered into Amendment No. 6 to the Loan and Security Agreement (the "Amended Loan and Security Agreement") and No. 2 Amended and Restated Secured Promissory Note (the "Amended Note") to further extend the maturity date to September 30, 2025 (the "Maturity Date") and pay the outstanding accrued interest as follows: (i) a payment of all accrued interest outstanding within five (5) business days of execution of the Amended Loan and Security Agreement; (ii) a payment of accrued interest on September 30, 2024 and (iii) thereafter all accrued interest due shall be payable on the Maturity Date. In addition, the Company may elect to repay all or any part of the Amended Note in its sole discretion at any time prior to the Maturity Date, provided such repayment shall not be less than $50,000 and shall first be applied to accrued interest and thereafter to the outstanding principal amount.